TY - JOUR
T1 - Biomarkers and Pharmacogenomics in Kidney Transplantation
AU - Crowley, L. E.
AU - Mekki, M.
AU - Chand, S.
N1 - Publisher Copyright:
© 2018, Springer International Publishing AG, part of Springer Nature.
PY - 2018/10/1
Y1 - 2018/10/1
N2 - This review is focused on present and future biomarkers, along with pharmacogenomics used in clinical practice for kidney transplantation. It aims to highlight biomarkers that could potentially be used to improve kidney transplant early and long-term graft survival, but also potentially patient co-morbidity. Future directions for improving outcomes are discussed, which include immune tolerance and personalising immunosuppression regimens.
AB - This review is focused on present and future biomarkers, along with pharmacogenomics used in clinical practice for kidney transplantation. It aims to highlight biomarkers that could potentially be used to improve kidney transplant early and long-term graft survival, but also potentially patient co-morbidity. Future directions for improving outcomes are discussed, which include immune tolerance and personalising immunosuppression regimens.
UR - http://www.scopus.com/inward/record.url?scp=85049596444&partnerID=8YFLogxK
U2 - 10.1007/s40291-018-0349-5
DO - 10.1007/s40291-018-0349-5
M3 - Review article
C2 - 29971647
AN - SCOPUS:85049596444
SN - 1177-1062
VL - 22
SP - 537
EP - 550
JO - Molecular Diagnosis and Therapy
JF - Molecular Diagnosis and Therapy
IS - 5
ER -